Related Experiment Video

Updated: Jun 2, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Drug eluting stent and coronary chronic total occlusions

G Niccoli1, A Leo, S Giubilato

  • 1Institute of Cardiology, Sacro Cuore Catholic University, Rome, Italy. gniccoli73@hotmail.it

Minerva Cardioangiologica
|April 26, 2011
PubMed

Insights

Drug-eluting stents (DES) improve outcomes for chronic total occlusion (CTO) interventions by reducing restenosis. However, long-term challenges with DES in CTO treatment require further investigation.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Chronic total occlusion (CTO) is a frequent and complex finding in coronary angiography.
  • CTO interventions pose significant challenges for interventional cardiologists.
  • Advancements in guidewires and techniques have improved CTO crossing success rates.

Purpose of the Study:

  • To review the current knowledge on stent application in CTO treatment.
  • To specifically focus on the use of drug-eluting stents (DES) in CTO.
  • To highlight emerging challenges and long-term outcomes associated with DES in CTO.

Main Methods:

  • Review of current literature on CTO recanalization and stenting.
  • Analysis of the impact of bare metal stents and DES on CTO outcomes.
  • Examination of short- and mid-term follow-up data post-CTO recanalization.

Main Results:

  • Drug-eluting stents (DES) have significantly reduced restenosis and target lesion revascularization compared to bare metal stents.
  • Improved success rates in crossing CTO lesions have been achieved with new technologies.
  • Unresolved issues concerning the long-term efficacy and safety of DES in CTO are emerging.

Conclusions:

  • DES have enhanced short- and mid-term outcomes in CTO interventions.
  • Further research is needed to address the long-term implications of DES use in CTO.
  • Optimizing DES strategies for CTO is crucial for improving patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...